Both mild and moderate-to-severe psoriasis are significantly associated with an increased risk for sleep disorders, according ...

Inflammation is the body’s response to illness or injury in an effort to try and restore health. NBC News medical fellow Dr. Akshay Syal details how to fight chronic inflammation. Real estate agent ...

Bimekizumab use for 4 years among patients with plaque psoriasis is associated with sustained efficacy outcomes and no new safety signals.

Discover a study in which researchers examined three international cohorts of patients with moderate-to-severe psoriasis ...

For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers in blood, characterized by high-sensitivity C-reactive protein, despite ...